Red, yellow, and green swirls on a black background

Researchers found that the optic nerve sheath that connects the eye and brain also functions as a lymphatic drainage system, shown here in a mouse. Lymphatic cell protein markers that are expressed inside the sheath are stained in green and red.

Credit: Eric Song

The optic nerve may help protect the brain from sickness

Researchers discovered an immunological connection between the eye and the brain that could lead to new therapeutics for central nervous system diseases.
Allison Whitten
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

To process the complex visual world, the eye connects to the brain through the optic nerve. Light enters the eye and quickly converts into electrical signals that flow along the optic nerve until they arrive at the occipital cortex. Scientists believed that this was the only direct connection between the eye and brain. Yet, when Eric Song, an immunologist and ophthalmology resident at Yale School of Medicine, and his colleagues began investigating where the drugs from eye injections end up, they found a previously hidden immunological nexus between the eye and the brain (1).  

Song’s team showed that the optic nerve also serves as a lymphatic drainage system that leads to shared immune responses between the eye and brain. Specifically, a compartment at the back of the eye drains from the optic nerve into the same lymph nodes in the neck that collect cerebrospinal fluid. The finding unlocks new opportunities to explore therapeutic treatments for diseases of the eye and central nervous system.

“This really opens the door to stop thinking about the eye and the brain as a signaling privileged organ and isolated organ, but an organ system that really interacts with each other through an immunological pathway,” said Song.

This is really the beginning of trying to understand how the eye can be a sensor for things that are happening in the central nervous system beyond just light sensing. 
– Eric Song, Yale School of Medicine

In the new work, Song’s team discovered that the lymphatic vessels that exist along the optic nerve sheath are conserved across diverse species in humans, primates, pigs, and even zebrafish. In mice, the researchers injected viral and bacterial intravitreal immunizations at the back of the eye and demonstrated that the immune responses were similar to those from local immunizations in the brain. They also showed that effective immune responses to brain tumors in mice could be generated via intravitreal immunizations.

“As you can imagine, we're not going to go around immunizing people into the eye just to have a protective immune response in the brain. So, we thought about in what kind of scenario …   can we take advantage of this new finding?” said Song. They decided to test whether they could dampen immune responses that limit the effectiveness of retinal dystrophy gene therapy over time. By blocking the lymphatic signaling on the optic nerve in mice, they successfully reduced the immune response and improved the efficacy of gene therapy.

Now, Song’s team is studying how the optic nerve sheath lymphatic system influences diseases of the central nervous system and how they can manipulate it for therapeutic benefits. “The lymphatic system is an interesting system because there's actually no pharmacological agents or drugs that can stimulate lymphatics,” Song said.

The new results also invite investigations to probe whether the eye can alert the brain to incoming threats. “This is really the beginning of trying to understand how the eye can be a sensor for things that are happening in the central nervous system beyond just light sensing,” said Song. “It's really exciting to know that there's still a lot to be discovered … It's right under our noses.” 

References

  1. Yin, X. et al. Compartmentalized ocular lymphatic system mediates eye–brain immunity. Nature  628, 204–211 (2024).

About the Author

  • Allison Whitten
    Allison Whitten joined Drug Discovery News as an assistant editor in 2023. She earned her PhD from Vanderbilt University in 2018, and has written for WIRED, Discover Magazine, Quanta Magazine, and more.

Related Topics

Published In

DDN July 2024 Magazine Issue
Volume 20 - Issue 4 | July 2024

July 2024

July 2024 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

An illustration of the tumor microenvironment, showing cancer cells, T cells, and nanoparticles interacting within a complex biological system

A closer look at the tumor microenvironment 

New technologies are allowing researchers to delve deeper into the complex tumor landscape.
An image of a western blot transfer showing the white, square transfer membrane with orange and blue bands representing the protein molecules undergoing transfer on a black and white machine.

Exploring stain-free western blotting

Researchers can achieve seamless western blot experiments by implementing advancements in stain-free technology, normalization methods, and compliance integration. 
A digital representation of a DNA double helix surrounded by molecular structures and chemical formulas.

Streamlining biopharmaceutical analysis with digital solutions

Discover how digitization improves data integrity and accelerates decision-making in biotherapeutics development. 
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue